Non-coding RNAs in stroke and neuroprotection

Frontiers in Neurology

Volumn 6, Issue MAR, 2015, Pages

  Saugstad, Julie A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cerebral ischemia; MicroRNA; Neuroprotection; Non coding RNA; Preconditioning

Indexed keywords

BORTEZOMIB; HYPOXIC PRECONDITIONING; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 103 1; MICRORNA 124; MICRORNA 132; MICRORNA 134; MICRORNA 181B; MICRORNA 21; MICRORNA 29; MICRORNA 29B; MICRORNA 30A; MICRORNA 347; MICRORNA 424; MICRORNA 497; PIWI INTERACTING RNA; TISSUE PLASMINOGEN ACTIVATOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VALPROIC ACID;

3' UNTRANSLATED REGION; ASTROCYTE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DOWN REGULATION; GENE EXPRESSION; HIBERNATION; HUMAN; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; REVIEW; TORPOR; UPREGULATION;

EID: 84926488390     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00050     Document Type: Review

References (120)

1. Vemuganti R. All's well that transcribes well: non-coding RNAs and post- stroke brain damage. Neurochem Int (2013) 63:438-49. doi: 10.1016/j.neuint.2013.07.014
2. Bhalala OG, Srikanth M, Kessler JA. The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol (2013) 9:328-39. doi:10.1038/nrneurol.2013.67
3. Yin KJ, Hamblin M, Chen YE. Non-coding RNAs in cerebral endothelial pathophysiology: emerging roles in stroke. Neurochem Int (2014) 77:9-16. doi:10.1016/j.neuint.2014.03.013
4. Yan H, Fang M, Liu XY. Role of microRNAs in stroke and poststroke depression. ScientificWorldJournal (2013) 2013:459692. doi:10.1155/2013/459692
5. Wang Y, Wang Y, Yang GY. MicroRNAs in cerebral ischemia. Stroke Res Treat (2013) 2013:276540. doi:10.1155/2013/276540
6. Liu XS, Chopp M, Zhang RL, Zhang ZG. MicroRNAs in cerebral ischemia-induced neurogenesis. J Neuropathol Exp Neurol (2013) 72:718-22. doi:10.1097/NEN.0b013e31829e4963
7. Liu FJ, Lim KY, Kaur P, Sepramaniam S, Armugam A, Wong PT, et al. microRNAs involved in regulating spontaneous recovery in embolic stroke model. PLoS One (2013) 8:e66393. doi:10.1371/journal.pone.0066393
8. Kukreja RC, Yin C, Salloum FN. MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol (2011) 80:558-64. doi:10.1124/mol.111.073528
9. Lodish HF. Translational control of protein synthesis. Annu Rev Biochem (1976) 45:39-72. doi:10.1146/annurev.bi.45.070176.000351
10. Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell (2014) 157:77-94. doi:10.1016/j.cell.2014.03.008
11. Matera AG, Wang Z. A day in the life of the spliceosome. Nat Rev Mol Cell Biol (2014) 15:108-21. doi:10.1038/nrm3778
12. Bratkovic T, Rogelj B. The many faces of small nucleolar RNAs. Biochim Biophys Acta (2014) 1839:438-43. doi:10.1016/j.bbagrm.2014.04.009
13. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol (2005) 15:331-41. doi:10.1016/j.sbi.2005.05.006
14. Kaur P, Liu F, Tan JR, Lim KY, Sepramaniam S, Karolina DS, et al. Non-coding RNAs as potential neuroprotectants against ischemic brain injury. Brain Sci (2013) 3:360-95. doi:10.3390/brainsci3010360
15. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol (2014) 15:509-24. doi:10.1038/nrm3838
16. Iyengar BR, Choudhary A, Sarangdhar MA, Venkatesh KV, Gadgil CJ, Pillai B. Non-coding RNA interact to regulate neuronal development and function. Front Cell Neurosci (2014) 8:47. doi:10.3389/fncel.2014.00047
17. Petri R, Malmevik J, Fasching L, Akerblom M, Jakobsson J. miRNAs in brain development. Exp Cell Res (2014) 321:84-9. doi:10.1016/j.yexcr.2013.09.022
18. Sun E, Shi Y. MicroRNAs: small molecules with big roles in neurodevelopment and diseases. Exp Neurol (2014). doi:10.1016/j.expneurol.2014.08.005
19. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A (2006) 103:2422-7. doi:10.1073/pnas.0511041103
20. Jovicic A, Roshan R, Moisoi N, Pradervand S, Moser R, Pillai B, et al. Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci (2013) 33:5127-37. doi:10.1523/JNEUROSCI.0600-12.2013
21. Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, Kim TK, et al. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J (2009) 28:697-710. doi:10.1038/emboj.2009.10
22. Magill ST, Cambronne XA, Luikart BW, Lioy DT, Leighton BH, Westbrook GL, et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A (2010) 107:20382-7. doi:10.1073/pnas.1015691107
23. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, et al. A brain-specific microRNA regulates dendritic spine development. Nature (2006) 439:283-9. doi:10.1038/nature04367
24. Aksoy-Aksel A, Zampa F, Schratt G. MicroRNAs and synaptic plasticity - a mutual relationship. Philos Trans R Soc Lond B Biol Sci (2014) 369:20130515. doi:10.1098/rstb.2013.0515
25. Bredy TW, Lin Q, Wei W, Baker-Andresen D, Mattick JS. MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem (2011) 96:89-94. doi:10.1016/j.nlm.2011.04.004
26. Olde Loohuis NF, Kos A, Martens GJ, Van Bokhoven H, Nadif Kasri N, Aschrafi A. MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci (2012) 69:89-102. doi:10.1007/s00018-011-0788-1
27. Paschou M, Paraskevopoulou MD, Vlachos IS, Koukouraki P, Hatzigeorgiou AG, Doxakis E. miRNA regulons associated with synaptic function. PLoS One (2012) 7:e46189. doi:10.1371/journal.pone.0046189
28. Siegel G, Saba R, Schratt G. microRNAs in neurons: manifold regulatory roles at the synapse. Curr Opin Genet Dev (2011) 21:491-7. doi:10.1016/j.gde.2011.04.008
29. Tognini P, Pizzorusso T. MicroRNA212/132 family: molecular transducer of neuronal function and plasticity. Int J Biochem Cell Biol (2012) 44:6-10. doi:10.1016/j.biocel.2011.10.015
30. Wibrand K, Pai B, Siripornmongcolchai T, Bittins M, Berentsen B, Ofte ML, et al. MicroRNA regulation of the synaptic plasticity-related gene Arc. PLoS One (2012) 7:e41688. doi:10.1371/journal.pone.0041688
31. Chivet M, Javalet C, Hemming F, Pernet-Gallay K, Laulagnier K, Fraboulet S, et al. Exosomes as a novel way of interneuronal communication. Biochem Soc Trans (2013) 41:241-4. doi:10.1042/BST20120266
32. Fruhbeis C, Frohlich D, Kuo WP, Kramer-Albers EM. Extracellular vesicles as mediators of neuron-glia communication. Front Cell Neurosci (2013) 7:182. doi:10.3389/fncel.2013.00182
33. Sharma P, Schiapparelli L, Cline HT. Exosomes function in cell-cell communication during brain circuit development. Curr Opin Neurobiol (2013) 23:997-1004. doi:10.1016/j.conb.2013.08.005
34. Rajendran L, Bali J, Barr MM, Court FA, Kramer-Albers EM, Picou F, et al. Emerging roles of extracellular vesicles in the nervous system. J Neurosci (2014) 34:15482-9. doi:10.1523/JNEUROSCI.3258-14.2014
35. Garnier D, Jabado N, Rak J. Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours. Proteomics (2013) 13:1595-607. doi:10.1002/pmic.201200360
36. El Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 12:347-57. doi:10.1038/nrd3978
37. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 10:155-9. doi:10.1038/nrg2521
38. Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol (2013) 425(19):3723-30. doi:10.1016/j.jmb.2012.11.024
39. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A (2008) 105:716-21. doi:10.1073/pnas.0706729105
40. Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci (2012) 13:528-41. doi:10.1038/nrn3234
41. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res (2010) 1338:20-35. doi:10.1016/j.brainres.2010.03.110
42. Qureshi IA, Mehler MF. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics (2013) 10:632-46. doi:10.1007/s13311-013-0199-0
43. Weick EM, Miska EA. piRNAs: from biogenesis to function. Development (2014) 141:3458-71. doi:10.1242/dev.094037
44. Meister G. Argonaute proteins: functional insights and emerging roles. Nat Rev Genet (2013) 14:447-59. doi:10.1038/nrg3462
45. Das PP, Bagijn MP, Goldstein LD, Woolford JR, Lehrbach NJ, Sapetschnig A, et al. Piwi and piRNAs act upstream of an endogenous siRNA pathway to suppress Tc3 transposon mobility in the Caenorhabditis elegans germline. Mol Cell (2008) 31:79-90. doi:10.1016/j.molcel.2008.06.003
46. Houwing S, Kamminga LM, Berezikov E, Cronembold D, Girard A, van den Elst H, et al. A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish. Cell (2007) 129:69-82. doi:10.1016/j.cell.2007.03.026
47. Vagin VV, Sigova A, Li C, Seitz H, Gvozdev V, Zamore PD. A distinct small RNA pathway silences selfish genetic elements in the germline. Science (2006) 313:320-4. doi:10.1126/science.1129333
48. Malone CD, Hannon GJ. Small RNAs as guardians of the genome. Cell (2009) 136:656-68. doi:10.1016/j.cell.2009.01.045
49. Landry CD, Kandel ER, Rajasethupathy P. New mechanisms in memory storage: piRNAs and epigenetics. Trends Neurosci (2013) 36:535-42. doi:10.1016/j.tins.2013.05.004
50. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke (2008) 39:959-66. doi:10.1161/STROKEAHA.107.500736
51. Dharap A, Bowen K, Place R, Li LC, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab (2009) 29:675-87. doi:10.1038/jcbfm.2008.157
52. Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, et al. Expression profile of MicroRNAs in young stroke patients. PLoS One (2009) 4:e7689. doi:10.1371/journal.pone.0007689
53. Wang C, Pan Y, Cheng B, Chen J, Bai B. Identification of conserved and novel micrornas in cerebral ischemia-reperfusion injury of rat using deep sequencing. J Mol Neurosci (2014) 54(4):671-83. doi:10.1007/s12031-014-0383-7
54. Murphy SJ, McCullough LD, Smith JM. Stroke in the female: role of biological sex and estrogen. ILAR J (2004) 45:147-59. doi:10.1093/ilar.45.2.147
55. Siegel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci U S A (2011) 108:11662-7. doi:10.1073/pnas.1102635108
56. Lusardi TA, Murphy SJ, Phillips JI, Chen Y, Davis CM, Young JM, et al. MicroRNA responses to focal cerebral ischemia in male and female mouse brain. Front Mol Neurosci (2014) 7:11. doi:10.3389/fnmol.2014.00011
57. Murphy SJ, Lusardi TA, Phillips JI, Saugstad JA. Sex differences in microRNA expression during development in rat cortex. Neurochem Int (2014) 77:24-32. doi:10.1016/j.neuint.2014.06.007
58. Selvamani A, Williams MH, Miranda RC, Sohrabji F. Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin Sci (Lond) (2014) 127:77-89. doi:10.1042/CS20130565
59. Yin KJ, Deng Z, Huang H, Hamblin M, Xie C, Zhang J, et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis (2010) 38(1):17-26. doi:10.1016/j.nbd.2009.12.021
60. Chen J, Simon RP, Nagayama T, Zhu R, Loeffert JE, Watkins SC, et al. Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death. J Cereb Blood Flow Metab (2000) 20:1033-9. doi:10.1097/00004647-200007000-00002
61. Linnik MD, Zahos P, Geschwind MD, Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke (1995) 26:1670-4. doi:10.1161/01.STR.26.9.1670
62. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 13:1017-30. doi:10.1016/0896-6273(94)90266-6
63. Sun Y, Jin K, Clark KR, Peel A, Mao XO, Chang Q, et al. Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia. Gene Ther (2003) 10:115-22. doi:10.1038/sj.gt.3301868
64. Shi G, Liu Y, Liu T, Yan W, Liu X, Wang Y, et al. Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp Brain Res (2012) 216:225-30. doi:10.1007/s00221-011-2925-3
65. Huang W, Liu X, Cao J, Meng F, Li M, Chen B, et al. miR-134 regulates ischemia/reperfusion injury-induced neuronal cell death by regulating CREB signaling. J Mol Neurosci (2014) 2:1-9. doi:10.1007/s12031-014-0434-0
66. Buller B, Liu X, Wang X, Zhang RL, Zhang L, Hozeska-Solgot A, et al. MicroRNA-21 protects neurons from ischemic death. FEBS J (2010) 277:4299-307. doi:10.1111/j.1742-4658.2010.07818.x
67. Gubern C, Camos S, Ballesteros I, Rodriguez R, Romera VG, Canadas R, et al. miRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis. FEBS J (2013) 280:6233-46. doi:10.1111/febs.12546
68. Ziu M, Fletcher L, Rana S, Jimenez DF, Digicaylioglu M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One (2011) 6:e14724. doi:10.1371/journal.pone.0014724
69. Ouyang YB, Lu Y, Yue S, Xu LJ, Xiong XX, White RE, et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis (2012) 45:555-63. doi:10.1016/j.nbd.2011.09.012
70. Ouyang YB, Giffard RG. MicroRNAs regulate the chaperone network in cerebral ischemia. Transl Stroke Res (2013) 4:693-703. doi:10.1007/s12975-013-0280-3
71. Dhiraj DK, Chrysanthou E, Mallucci GR, Bushell M. miRNAs-19b, -29b-2*and -339-5p show an early and sustained up-regulation in ischemic models of stroke. PLoS One (2013) 8:e83717. doi:10.1371/journal.pone.0083717
72. Dharap A, Nakka VP, Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke (2012) 43:2800-2. doi:10.1161/STROKEAHA.112.669465
73. Dharap A, Pokrzywa C, Vemuganti R. Increased binding of stroke-induced long non-coding RNAs to the transcriptional corepressors Sin3A and coREST. ASN Neuro (2013) 5:283-9. doi:10.1042/AN20130029
74. Lee EJ, Banerjee S, Zhou H, Jammalamadaka A, Arcila M, Manjunath BS, et al. Identification of piRNAs in the central nervous system. RNA (2011) 17:1090-9. doi:10.1261/rna.2565011
75. Dharap A, Nakka VP, Vemuganti R. Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke (2011) 42:1105-9. doi:10.1161/STROKEAHA.110.598391
76. Rejdak R, Rejdak K, Sieklucka-Dziuba M, Stelmasiak Z, Grieb P. Brain tolerance and preconditioning. Pol J Pharmacol (2001) 53:73-9.
77. Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X, et al. Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog Neurobiol (2014) 114:58-83. doi:10.1016/j.pneurobio.2013.11.005
78. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke (1998) 29:1937-50. doi:10.1161/01.STR.29.9.1937
79. Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke (2007) 38:680-5. doi:10.1161/01.STR.0000251444.56487.4c
80. Stenzel-Poore MP, Stevens SL, Simon RP. Genomics of preconditioning. Stroke (2004) 35:2683-6. doi:10.1161/01.STR.0000143735.89281.bb
81. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (2003) 362:1028-37. doi:10.1016/S0140-6736(03)14412-1
82. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, et al. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res (1991) 561:203-11. doi:10.1016/0006-8993(91)91596-S
83. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res (1990) 528:21-4. doi:10.1016/0006-8993(90)90189-I
84. Lusardi TA, Farr CD, Faulkner CL, Pignataro G, Yang T, Lan J, et al. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab (2010) 30:744-56. doi:10.1038/jcbfm.2009.253
85. Chahrour M, Jung SY, Shaw C, Zhou X, Wong STC, Qin J, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 320:1224-9. doi:10.1126/science.1153252
86. Feng Y, Huang W, Wani M, Yu X, Ashraf M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One (2014) 9:e88685. doi:10.1371/journal.pone.0088685
87. Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem (2010) 113:1685-91. doi:10.1111/j.1471-4159.2010.06735.x
88. Lee ST, Chu K, Jung KH, Yoon HJ, Jeon D, Kang KM, et al. MicroRNAs induced during ischemic preconditioning. Stroke (2010) 41:1646-51. doi:10.1161/STROKEAHA.110.579649
89. Bu X, Zhang N, Yang X, Liu Y, Du J, Liang J, et al. Proteomic analysis of cPKCbetaII-interacting proteins involved in HPC-induced neuroprotection against cerebral ischemia of mice. J Neurochem (2011) 117:346-56. doi:10.1111/j.1471-4159.2011.07209.x
90. Liu C, Peng Z, Zhang N, Yu L, Han S, Li D, et al. Identification of differentially expressed microRNAs and their PKC-isoform specific gene network prediction during hypoxic pre-conditioning and focal cerebral ischemia of mice. J Neurochem (2012) 120:830-41. doi:10.1111/j.1471-4159.2011.07624.x
91. Kitano H, Kirsch JR, Hurn PD, Murphy SJ. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab (2007) 27:1108-28. doi:10.1038/sj.jcbfm.9600410
92. Cao L, Feng C, Li L, Zuo Z. Contribution of microRNA-203 to the isoflurane preconditioning-induced neuroprotection. Brain Res Bull (2012) 88:525-8. doi:10.1016/j.brainresbull.2012.05.009
93. Shi H, Sun BL, Zhang J, Lu S, Zhang P, Wang H, et al. miR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning. CNS Neurol Disord Drug Targets (2013) 12:381-91. doi:10.2174/1871527311312030011
94. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience (2009) 158:1007-20. doi:10.1016/j.neuroscience.2008.07.067
95. Vartanian K, Stenzel-Poore M. Toll-like receptor tolerance as a mechanism for neuroprotection. Transl Stroke Res (2010) 1:252-60. doi:10.1007/s12975-010-0033-5
96. Bahjat FR, Williams-Karnesky RL, Kohama SG, West GA, Doyle KP, Spector MD, et al. Proof of concept: pharmacological preconditioning with a toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke. J Cereb Blood Flow Metab (2011) 31:1229-42. doi:10.1038/jcbfm.2011.6
97. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, et al. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab (2008) 28:1040-7. doi:10.1038/sj.jcbfm.9600606
98. Vartanian KB, Mitchell HD, Stevens SL, Conrad VK, McDermott JE, Stenzel-Poore MP. CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury. J Cereb Blood Flow Metab (2014) 35(2):257-66. doi:10.1038/jcbfm.2014.193
99. Lee YJ, Castri P, Bembry J, Maric D, Auh S, Hallenbeck JM. SUMOylation participates in induction of ischemic tolerance. J Neurochem (2009) 109:257-67. doi:10.1111/j.1471-4159.2009.05957.x
100. Lee YJ, Miyake S, Wakita H, McMullen DC, Azuma Y, Auh S, et al. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J Cereb Blood Flow Metab (2007) 27:950-62. doi:10.1038/sj.jcbfm.9600395
101. Lee YJ, Johnson KR, Hallenbeck JM. Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia. PLoS One (2012) 7:e47787. doi:10.1371/journal.pone.0047787
102. Pandi G, Nakka VP, Dharap A, Roopra A, Vemuganti R. MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS One (2013) 8:e58039. doi:10.1371/journal.pone.0058039
103. Hwang JY, Kaneko N, Noh KM, Pontarelli F, Zukin RS. The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die. J Mol Biol (2014) 426:3454-66. doi:10.1016/j.jmb.2014.07.032
104. Peng Z, Li J, Li Y, Yang X, Feng S, Han S, et al. Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1. J Neurosci Res (2013) 91:1349-62. doi:10.1002/jnr.23255
105. Chi W, Meng F, Li Y, Li P, Wang G, Cheng H, et al. Impact of microRNA-134 on neural cell survival against ischemic injury in primary cultured neuronal cells and mouse brain with ischemic stroke by targeting HSPA12B. Brain Res (2014) 1592:22-33. doi:10.1016/j.brainres.2014.09.072
106. Wang P, Liang J, Li Y, Li J, Yang X, Zhang X, et al. Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy. Neurochem Res (2014) 39:1279-91. doi:10.1007/s11064-014-1310-6
107. Di Y, Lei Y, Yu F, Changfeng F, Song W, Xuming M. MicroRNAs expression and function in cerebral ischemia reperfusion injury. J Mol Neurosci (2014) 53:242-50. doi:10.1007/s12031-014-0293-8
108. Peng T, Jia YJ, Wen QQ, Guan WJ, Zhao EY, Zhang BA. [Expression of microRNA in neonatal rats with hypoxic-ischemic brain damage]. Zhongguo Dang Dai Er Ke Za Zhi (2010) 12:373-6.
109. Zhu F, Liu JL, Li JP, Xiao F, Zhang ZX, Zhang L. MicroRNA-124 (miR-124) regulates Ku70 expression and is correlated with neuronal death induced by ischemia/reperfusion. J Mol Neurosci (2014) 52:148-55. doi:10.1007/s12031-013-0155-9
110. Zhao H, Wang J, Gao L, Wang R, Liu X, Gao Z, et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke (2013) 44:1706-13. doi:10.1161/STROKEAHA.111.000504
111. Pignataro G, Gala R, Cuomo O, Tortiglione A, Giaccio L, Castaldo P, et al. Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke (2004) 35:2566-70. doi:10.1161/01.STR.0000143730.29964.93
112. Vinciguerra A, Formisano L, Cerullo P, Guida N, Cuomo O, Esposito A, et al. MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits. Mol Ther (2014) 22:1829-38. doi:10.1038/mt.2014.113
113. Shin JH, Park YM, Kim DH, Moon GJ, Bang OY, Ohn T, et al. Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway. Biochim Biophys Acta (2014) 1839:826-36. doi:10.1016/j.bbagrm.2014.06.019
114. Ouyang YB, Xu L, Yue S, Liu S, Giffard RG. Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neurosci Lett (2014) 565:53-8. doi:10.1016/j.neulet.2013.11.015
115. Hunsberger JG, Fessler EB, Wang Z, Elkahloun AG, Chuang DM. Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am J Transl Res (2012) 4:316-32.
116. Zhang L, Chopp M, Liu X, Teng H, Tang T, Kassis H, et al. Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway. Arterioscler Thromb Vasc Biol (2012) 32:1856-64. doi:10.1161/ATVBAHA.112.252619
117. Selvamani A, Sathyan P, Miranda RC, Sohrabji F. An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One (2012) 7:e32662. doi:10.1371/journal.pone.0032662
118. Bake S, Selvamani A, Cherry J, Sohrabji F. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One (2014) 9:e91427. doi:10.1371/journal.pone.0091427
119. Xiao S, Ma Y, Zhu H, Sun H, Yin Y, Feng G. miRNA functional synergistic network analysis of mice with ischemic stroke. Neurol Sci (2014) 36(1):143-8. doi:10.1007/s10072-014-1904-4
120. Colombo E, Borgiani B, Verderio C, Furlan R. Microvesicles: novel biomarkers for neurological disorders. Front Physiol (2012) 3:63. doi:10.3389/fphys.2012.00063